Jennifer L Good insider trades
Open-market stock purchases and sales by Jennifer L Good, Director at Rhythm Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 5, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +29%.